{"id":"https://openalex.org/W4361944397","doi":"https://doi.org/10.1158/1078-0432.c.6520124","title":"Data from Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","display_name":"Data from Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944397","doi":"https://doi.org/10.1158/1078-0432.c.6520124"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6520124","doi":"https://doi.org/10.1158/1078-0432.c.6520124","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6520124","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6520124","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006028648","display_name":"Patricia S. Fox","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia S. Fox","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103439037","display_name":"Nicholas E. Papadopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas E. Papadopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060563693","display_name":"Agop Y. Bedikian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agop Y. Bedikian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110089","display_name":"Wen\u2010Jen Hwu","orcid":"https://orcid.org/0000-0003-1674-0751","observed_orcids":["https://orcid.org/0000-0003-1674-0751"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-Jen Hwu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050445982","display_name":"Alexander J. Lazar","orcid":"https://orcid.org/0000-0002-6395-4499","observed_orcids":["https://orcid.org/0000-0002-6395-4499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander J. Lazar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087156478","display_name":"Victor Gerardo Prieto","orcid":"https://orcid.org/0000-0001-9204-7161","observed_orcids":["https://orcid.org/0000-0001-9204-7161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor G. Prieto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049265932","display_name":"Kirk Salvatore Culotta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirk S. Culotta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086839893","display_name":"Timothy L. Madden","orcid":"https://orcid.org/0000-0003-2954-4776","observed_orcids":["https://orcid.org/0000-0003-2954-4776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy L. Madden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111438686","display_name":"Quanyun Alan Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Quanyun Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081018877","display_name":"Sha Huang","orcid":"https://orcid.org/0000-0001-8419-0320","observed_orcids":["https://orcid.org/0000-0001-8419-0320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sha Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904352","display_name":"Wanleng Deng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wanleng Deng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053460346","display_name":"Chaan S. Ng","orcid":"https://orcid.org/0000-0001-9261-7021","observed_orcids":["https://orcid.org/0000-0001-9261-7021"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chaan S. Ng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016712439","display_name":"Sanjay Gupta","orcid":"https://orcid.org/0000-0002-9492-3249","observed_orcids":["https://orcid.org/0000-0002-9492-3249"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjay Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373260","display_name":"Wenbin Liu","orcid":"https://orcid.org/0000-0002-9080-8040","observed_orcids":["https://orcid.org/0000-0002-9080-8040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenbin Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015598221","display_name":"Janet Ellen Dancey","orcid":"https://orcid.org/0000-0001-8356-0019","observed_orcids":["https://orcid.org/0000-0001-8356-0019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet E. Dancey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"John J. Wright","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Wright","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027845051","display_name":"Roland L. Bassett","orcid":"https://orcid.org/0000-0002-4534-2042","observed_orcids":["https://orcid.org/0000-0002-4534-2042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roland L. Bassett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033798832","display_name":"Patrick Hwu","orcid":"https://orcid.org/0000-0002-8293-1313","observed_orcids":["https://orcid.org/0000-0002-8293-1313","https://orcid.org/0000-0003-0554-2856"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Hwu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015498468","display_name":"Kevin B. Kim","orcid":"https://orcid.org/0000-0003-0694-0530","observed_orcids":["https://orcid.org/0000-0003-0694-0530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin B. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.6740000247955322},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.5979999899864197},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.8339999914169312},{"id":"https://openalex.org/keywords/ribosomal-protein-s6-phosphorylation","display_name":"S6 phosphorylation","score":0.921999990940094},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7260000109672546},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.8090000152587891},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.8618500232696533},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8507271409034729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7189918756484985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6211381554603577},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.4554881155490875},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4109314978122711},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3674023747444153},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2897305488586426},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.27988481521606445},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.08310127258300781},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08261260390281677},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.06358188390731812},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.054760128259658813},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6520124","doi":"https://doi.org/10.1158/1078-0432.c.6520124","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6520124","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6520124.v1","doi":"https://doi.org/10.1158/1078-0432.c.6520124.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6520124.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6520124","doi":"https://doi.org/10.1158/1078-0432.c.6520124","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6520124","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2144547786","https://openalex.org/W2284111640","https://openalex.org/W2285190282","https://openalex.org/W2149646251","https://openalex.org/W2031162007","https://openalex.org/W4240228356","https://openalex.org/W2248900863","https://openalex.org/W2595040182","https://openalex.org/W2130470864","https://openalex.org/W2245539971"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"This":[2],"phase":[3],"I":[4],"clinical":[5,244],"trial":[6],"was":[7,54,63,197],"conducted":[8],"to":[9,49,138,241],"determine":[10],"the":[11,103,139,181],"safety,":[12],"efficacy,":[13],"and":[14,27,40,61,101,117,119,127,151,156,171,202,230,251],"molecular":[15],"effects":[16],"of":[17,47,106,122,133,187,210,216,223],"sorafenib":[18,146,229],"with":[19,23,30,72,92,180,212,228],"temsirolimus":[20,62,157,231],"in":[21,86,115,214,233,246],"patients":[22,91,135,184],"advanced":[24],"melanoma.":[25],"Patients":[26,29],"Methods:":[28],"stage":[31,37],"IV":[32],"or":[33,35,58,177],"unresectable":[34],"recurrent":[36],"III":[38],"melanoma":[39],"Eastern":[41],"Cooperative":[42],"Oncology":[43],"Group":[44],"performance":[45],"status":[46],"0":[48],"1":[50],"were":[51,77,110,136,145,174],"eligible.":[52],"Sorafenib":[53],"given":[55,64],"orally":[56],"once":[57],"twice":[59],"daily":[60],"i.v.":[65,160],"weekly,":[66],"both":[67],"starting":[68],"on":[69],"day":[70,203],"1,":[71],"a":[73],"4-week":[74],"cycle.":[75],"Responses":[76],"assessed":[78],"every":[79,149,154],"2":[80],"cycles":[81],"per":[82],"Response":[83],"Evaluation":[84],"Criteria":[85],"Solid":[87],"Tumors":[88],"criteria.":[89],"Consenting":[90],"accessible":[93],"tumors":[94],"underwent":[95],"optional":[96],"tumor":[97,205],"biopsies":[98,109,206],"before":[99],"treatment":[100,213],"after":[102],"second":[104],"infusion":[105],"temsirolimus.":[107],"Tumor":[108],"analyzed":[111],"for":[112,120],"activating":[113],"mutations":[114],"BRAF":[116],"NRAS,":[118],"expression":[121],"P-extracellular":[123],"signal-regulated":[124],"kinase":[125],"(P-ERK)":[126],"P-S6":[128,211],"proteins.":[129],"Results:":[130],"A":[131],"total":[132],"25":[134,158],"accrued":[137],"study.":[140],"The":[141,193],"maximum":[142],"tolerated":[143],"doses":[144],"400":[147],"mg":[148,153,159],"morning":[150],"200":[152],"evening":[155],"weekly.":[161],"Dose-limiting":[162],"toxicities":[163],"included":[164],"thrombocytopenia,":[165],"hand-foot":[166],"syndrome,":[167],"serum":[168],"transaminase":[169],"elevation,":[170],"hypertriglyceridemia.":[172],"There":[173],"no":[175],"complete":[176],"partial":[178],"responses":[179,245],"combination;":[182],"10":[183],"achieved":[185],"stabilization":[186],"disease":[188],"as":[189],"their":[190],"best":[191],"response.":[192],"median":[194],"progression-free":[195],"survival":[196],"2.1":[198],"months.":[199],"Matching":[200],"pretreatment":[201],"15":[204],"showed":[207],"marked":[208],"inhibition":[209,222],"3":[215],"4":[217],"evaluable":[218],"patients,":[219],"but":[220],"minimal":[221],"P-ERK.":[224,255],"Conclusions:":[225],"Combination":[226],"therapy":[227],"resulted":[232],"significant":[234],"toxicity":[235],"at":[236],"higher":[237],"dose":[238],"levels,":[239],"failed":[240],"achieve":[242],"any":[243],"genetically":[247],"unselected":[248],"patient":[249],"population,":[250],"did":[252],"not":[253],"inhibit":[254],"Clin":[256],"Cancer":[257],"Res;":[258],"18(4);":[259],"1120\u20138.":[260],"\u00a92012":[261],"AACR.":[262]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}